Replies to post #62135 on NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

"The study is still open, so we don't know the results, but we like what we're seeing." Dr. Gruber, Nov 2013 in Overlook View

Dr. Gruber is the PI at NYU and Overlook. He joined early on, if you remember; and those sites reached maximum recruitment and were closed to new screening. The section of an article below - it was nice to see that he was still actively involved in the DCVax-L study last year:

"The vaccine under study, called “DCVax,” is unique in that it takes advantage of the ability of white blood cells to recognize – and destroy – a patient’s cancer cells, said Dr. Yaron Moshel, a neurosurgeon with Atlantic NeuroSurgical Specialists of Morristown.

Moshel, who is also co-director of the Brain Tumor Center of New Jersey, performed brain tumor surgery on Coakley earlier this year. After the successful tumor removal, Coakley agreed to participate in the DCVax trial under the guidance of Moshel’s colleague at the center, Dr. Michael Gruber."